Continued Innovation – Holotype HLA V2.2

30/11/2017

Omixon is delighted to announce the latest evolution of our world-leading HLA Typing product – Holotype HLA V2.1 and V2.2. Both versions deliver improved amplification robustness, increased allele coverage across Class II loci and decreased the library preparation turnaround time to ~4.3h. The major difference between V2.1 and V2.2...

Lab “Train Me” Video: How to Set Up the Holotype HLA Lab

07/11/2017

Welcome to our latest lab Train Me video! This time Efi Melista, Omixon’s Head of Field and Lab Operations will be describing how the workflow works and how you can set up your own Holotype HLA lab efficiently. To check all our previous Train Me videos, please visit the...

Omixon and World Fusion Extend Their Partnership in Japan

27/10/2017

World Fusion is a leading bioinformatics company in Japan that focuses on therapeutic target discovery, gene expression analysis, and variant analysis. Their highly skilled and motivated team has been the successful marketer of Omixon’s software products since 2014, and we are pleased to announce World Fusion as a distributor...

Blogging the Trends from ASHI 2017

26/10/2017

ASHI was also very educational for us and proved to be an excellent platform to identify the current trends in the HLA field. All the scientific presentations at the conference were outstanding, and provided us with a better understanding on what the HLA community is working on. We noticed...

HLA and The City – Omixon at ASHI 2017

24/10/2017

First of all, thank you to all our customers, distributors, friends and everyone else for visiting us and joining our events during the 43rd Annual ASHI 2017 Meeting! This year the Omixon Team – Efi, Maggi, Ellia, Nora, Kriszta, Pete, Faisal, Marcello and Attila – went on a trip...